The Beauty Health Company (NASDAQ:SKIN) Given Average Recommendation of “Hold” by Analysts

Shares of The Beauty Health Company (NASDAQ:SKIN) have been assigned an average recommendation of “Hold” from the seven analysts that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $1.3750.

Several brokerages have recently issued reports on SKIN. TD Cowen cut their price target on shares of Beauty Health from $1.00 to $0.90 and set a “hold” rating on the stock in a report on Wednesday, August 12th. Roth Capital restated a “buy” rating and issued a $2.00 price objective (down from $2.50) on shares of Beauty Health in a report on Wednesday, May 20th. Zacks Research lowered shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a report on Monday, July 20th. Finally, Weiss Ratings cut Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, July 23rd.

Beauty Health Price Performance

SKIN opened at $0.70 on Tuesday. The firm has a market cap of $91.10 million, a PE ratio of -3.18 and a beta of 1.00. The stock has a 50-day moving average price of $0.73 and a 200-day moving average price of $0.80. Beauty Health has a 1 year low of $0.55 and a 1 year high of $2.69. The company has a debt-to-equity ratio of 4.36, a current ratio of 1.76 and a quick ratio of 1.48.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings data on Thursday, August 6th. The company reported ($0.02) EPS for the quarter, meeting the consensus estimate of ($0.02). The company had revenue of $72.11 million for the quarter, compared to the consensus estimate of $74.45 million. Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. Sell-side analysts predict that Beauty Health will post -0.16 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Public Employees Retirement System of Ohio purchased a new stake in shares of Beauty Health during the third quarter valued at $26,000. Franklin Resources Inc. bought a new stake in Beauty Health in the 3rd quarter worth about $31,000. Zacks Investment Management purchased a new position in Beauty Health in the 3rd quarter worth about $35,000. Ameriprise Financial Inc. purchased a new position in Beauty Health in the 3rd quarter worth about $38,000. Finally, Atom Investors LP bought a new position in Beauty Health during the 4th quarter valued at about $29,000. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.